US 8722708
Substituted isoindolines as aspartyl protease inhibitors
granted A61PA61P13/12A61P25/00
Quick answer
US patent 8722708 (Substituted isoindolines as aspartyl protease inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P13/12, A61P25/00, A61P25/28, A61P31/10